NEW TREATMENT APPROACHES FOR NEURODEGENERATIVE DISORDERS
Article Sidebar
Main Article Content
Abstract
Abstract: Neurodegenerative disorders impose significant challenges in clinical practice, characterized by progressive neuronal degeneration and debilitating symptoms. This abstract provides an overview of emerging treatment strategies for neurodegenerative disorders, highlighting recent advances in gene therapy, precision medicine, immunotherapy, stem cell therapy, and neuroprotective strategies.
The field of gene therapy shows promise in targeting specific genetic abnormalities associated with neurodegenerative diseases, offering personalized and gene-specific interventions. Precision medicine, through biomarker development, enables tailored treatment plans based on individual genetic profiles and disease progression markers, enhancing therapeutic efficacy.
Article Details
References
Bashiri Nayak, H., Vinod, P. K., & Hazari, A. (2020). Telemedicine in COVID-19 pandemic: Role, challenges, and implications. (Journal of Clinical and Diagnostic Research, 14(6), VC01-VC04)
Hollander, J. E., & Carr, B. G. (2020). Virtually perfect? Telemedicine for COVID-19. (New England Journal of Medicine, 382(18), 1679-1681)
Greenhalgh, T., Wherton, J., Shaw, S., & Morrison, C. (2020). Video consultations for covid-19. (British Medical Journal, 368, m998)
Bhaskar, M. E., Arun, S., Reddy, S. B. N., Chalapathi, K. V., Trivendra, K., Hittar, RK.,...& Murara, SH. (2021). A systematic review and meta-analysis of telemedicine services for COVID-19. (American Journal of Journal, 287(2), 89-101)
Ohannessian R, Duong TA, & Odone A. (2020). Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action. (JMIR Public Health Surveillance
Kruse, C. S., Krowski, N., Rodriguez, B., & Tran, L. (2017). Varying perceptions of telemedicine in hospitals: an exploratory study. (Health Policy and Technology, 6(2), 169-178)